2A60.3ICD-11 MMS 2026-01
Acute myeloid leukaemia, not elsewhere classified by criteria of other types
Description
Acute myeloid leukaemias specified by morphological criteria should only be classified as such, if recurrent genetic abnormalities, prior history of a myelodysplastic syndrome or myelodysplastic/myeloproliferative neoplasm, or history of cytotoxic chemotherapy and/or radiotherapy are absent.
Excludes
Exclusions from above levels
2E03– Malignant neoplasm metastasis in bone or bone marrow- http://id.who.int/icd/entity/501778925 – Malignant neoplasm metastasis in lymph nodes
- http://id.who.int/icd/entity/97145147 – Malignant neoplasm metastasis in thymus gland
Child codes
2A60.30– Acute myeloid leukaemia with minimal differentiation2A60.31– Acute myeloid leukaemia without maturation2A60.32– Acute myeloid leukaemia with maturation2A60.33– Acute myelomonocytic leukaemia2A60.34– Acute monoblastic or monocytic leukaemia2A60.35– Acute erythroid leukaemia2A60.36– Acute megakaryoblastic leukaemia2A60.37– Acute basophilic leukaemia2A60.38– Acute panmyelosis with myelofibrosis2A60.39– Myeloid sarcoma2A60.3Y– Other specified acute myeloid leukaemia, not elsewhere classified by criteria of other types2A60.3Z– Acute myeloid leukaemia, unspecified
Sibling codes
2A60.0– Acute myeloid leukaemia with recurrent genetic abnormalities2A60.1– Acute myeloid leukaemia with myelodysplasia-related changes2A60.2– Therapy-related myeloid neoplasms2A60.4– Myeloid proliferation associated with Down syndrome2A60.5– Blastic plasmacytoid dendritic cell neoplasm2A60.Y– Other specified acute myeloid leukaemias and related precursor neoplasms2A60.Z– Acute myeloid leukaemias and related precursor neoplasms, unspecified
Foundation entity
Acute myeloid leukaemia, not elsewhere classified by criteria of other types – http://id.who.int/icd/entity/1611980611
Allowed postcoordination axes
Part of: 2A60: Acute myeloid leukaemias and related precursor neoplasms › 02: Neoplasms